Conference Proceedings

First-Line Lorlatinib Versus Crizotinib for Advanced Anaplastic Lymphoma Kinase-Positive (ALK plus ) NonSmall Cell Lung Cancer

A Shaw, T Bauer, T Takahashi, C Balk, Y Goto, A Polli, M Carpentieri, J Martini, B Solomon

JOURNAL OF THORACIC ONCOLOGY | ELSEVIER SCIENCE INC | Published : 2018